Neurobehavioral effects of Δ9-THC and cannabinoid (CB1) receptor gene expression in mice

Behavioural Brain Research

Volumn 72, Issue 1-2, 1995, Pages 115-125

  Onaivi, E S ^a   Chakrabarti, A ^a   Gwebu, E T ^b   Chaudhuri, G ^a  

^a MEHARRY MEDICAL COLLEGE   (United States)

^b OAKWOOD UNIVERSITY   (United States)

Author keywords

Antinociception; Anxiogenesis; Cannabinoid receptor gene; Catalepsy; CB1, cannabinoid receptor, brain type; CB2, cannabinoid receptor, peripheral tissue type; Marijuana receptor; Mouse strain; Neurobehavior; PCR, polymerase chain reaction; Psychoactivity; Tetrahydrocannabinol ( 9 THC)

Indexed keywords

CANNABINOID RECEPTOR; DRONABINOL;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BEHAVIOR; CONFERENCE PAPER; CONTROLLED STUDY; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMAL; ANXIETY; BASE SEQUENCE; BEHAVIOR, ANIMAL; BODY TEMPERATURE; CATALEPSY; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; MOTOR ACTIVITY; POLYMERASE CHAIN REACTION; RATS; REACTION TIME; RECEPTORS, DRUG; SPECIES SPECIFICITY; STEREOTAXIC TECHNIQUES; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TETRAHYDROCANNABINOL;

EID: 0029656070     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(96)00139-8     Document Type: Article

References (51)

1. Neurobiology of marijuana abuse
2. Cannabinoid receptor expression in human leukocytes
3. Characterization of the transcriptional initiation sites of the brain-type and the peripheral-type human cannabinoid receptor genes
4. 9-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study
5. MR/HAR and MNRA/HAR Maudsley rat strains: differential response to chlordiazepoxide in a conflict task
6. Sites of action of odansetron to inhibit withdrawal from drugs of abuse
7. 3 receptor agonist and antagonists for alteration of aversive behavior in the mouse
8. A method for determining loss of pain sensation
9. The role of the amygdala in fear and anxiety
10. DNA amplification in tunicamycin resistant Leishmania mexicana: multicopies of a single 63 kilobase supercoiled molecule and their expression
11. Enzymatic synthesis of anandamide, a cannabinoid receptor agonist
12. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
13. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone test
14. Effects of smoked marijuana on human social behavior in small groups
15. Strain-specific facilitation of reward by Δ-tetrahydrocannobinol in laboratory rats
16. Molecular cloning of a human cannobinoid receptor which is also expressed in testis
17. Use of recombinant inbred strains to identify quantitative trait loci in psychopharmacology
18. Biochemical mechanisms of constitutive and regulated pre-mRNA splicing
19. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study
20. Medical uses of marijuana?
21. Body temperature discriminates between full and partial benzodiazepine receptor antagonists
22. Hypothermia due to transient hypothalamic dysfunction in tuberculous meningitis with hydrocephalus
23. Introns as mobile genetic elements
24. Simple and rapid sample preparation methods for whole blood and blood plasma
25. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice
26. Mechanisms of alternative pre-mRNA splicing
27. Cellular effects of cannabinoids
28. Cannabinoid receptors: pharmacology, second messenger systems and endogenous ligands
29. Antinocicetive actions of cannabinoids following intraventricular administration in rats
30. Localization of cannabinoid receptor mRNA in rat brain
31. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
32. Differences in alcohol preference among inbred strains of mice
33. Genetic factors in alcohol preference in laboratory
34. Molecular characterization of a peripheral receptor for cannabinoids
35. Structures of dopamine receptors
36. Hypothalamic control of pituitary and adrenal hormones during hypothermia
37. Pharmacological characterization of cannabinoids in the elevated plus maze
38. Approaches to the determination of the central sites of action of cannabinoids
39. Comparison of behavioral and central BDZ binding profile in three rat lines
40. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
41. Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice
42. The ring test: a quantitative method for assessing the cataleptic effect of cannabis in mice
43. RNA binding proteins, splice site selection, and alternative pre-mRNA splicing
44. Reversible tetracaine block rat periaqueductal gray (PAG) decreases baseline tail-flick latency and prevents analgesic effects of met-enkephalin injection in nucleus paragigantocellularis (PGC)
45. 9-THC and the effects of various solubilizers
46. Effect of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drugs injected into the rat amygdala in a water lick suppression test
47. A strain comparison of physiological and locomotor response of mice to diisopropylfluorophosphate
48. Anxiolytic effects of benzodiazepines in amygdala-lesioned rats